# Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis

> **NCT07413549** · PHASE1,PHASE2 · RECRUITING · sponsor: **Beijing Tuohua Weiye Biotechnology Co., Ltd.** · enrollment: 76 (estimated)

## Conditions studied

- Decompensated Hepatitis B Cirrhosis

## Interventions

- **BIOLOGICAL:** Human Umbilical Cord Mesenchymal Stem Cells Injection

## Key facts

- **NCT ID:** NCT07413549
- **Lead sponsor:** Beijing Tuohua Weiye Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07413549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07413549, "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07413549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*